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ABSTRACT
Background." A concomitant infection with human immunodeficiency virus (HIV) may alter the
natural history of other infections. Several reports indicate that syphilis may behave more aggres-
sively when HIV infection is present.
Case: A woman presented with a rash involving her hands and feet and progressive loss of the
vision in her right eye. Her serologic tests for syphilis and HIV infection were positive. A diagnosis
of neurosyphilis was confirmed by an analysis of cerebrospinal fluid (CSF). She was treated with
high-dose intravenous (IV) penicillin. Her skin lesions resolved, but her vision did not improve.
Conclusion: The incidence of HIV infection among women is rising. A patient with HIV and
syphilis may develop neurosyphilis in a much shorter time than a patient without HIV
infection. (C) 1996 Wiley-Liss, Inc.
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32-year-old woman presented to the ophthal-
mology clinic with progressive loss of the vision
in her right eye and persistent, erythematous, li-
chenifie plaques on the palms of her hands and
the soles of her feet. Her visual loss had progressed
insidiously over the past year without acute change.
The lesions on her palms and soles had been pres-
ent for 6 years, with intermittent exacerbations and
partial remissions. A serum venereal disease re-
search laboratory (VDRL) test was positive at a
dilution of 1:256. She was admitted to the infectious
diseases service.
Ten years before, the patient had been evaluated
for a genital ulcer. A VDRL was negative. Three
years later, she was treated for gonorrhea at a local
health department clinic. Both VDRL and human
immunodeficiency virus (HIV) serologies were neg-
ative. Four years before her admission, she had
reported to the same clinic complaining of "spots"
on her hands and feet that occasionally "peeled,"
loss of her eyebrows, and thinning hair. A VDRL
was positive at a dilution of 1:128, and a test for
antibodies to HIV was positive. She was treated for
secondary syphilis with 2.4 million units of penicil-
lin G benzathine. Despite counseling, she did not
again seek medical attention until her presentation
to the ophthalmology clinic.
At the time of her admission to the infectious
diseases service, the patient appeared comfortable.
Her temperature was 37.1C. Her blood pressure
was 100/70 and pulse was 114. There was only light
perception in the right eye. The visual acuity in
the left eye was 20/25. Bilateral vitreal haziness
indicated active inflammation, but no vitreal cells.
The retinas showed bilateral salt-and-pepper pig-
mentary retinitis and bone-spiculed peripheral pig-
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Fig. I. Salt-and-pepper pigmentation of the retina with
bony spiculation (solid arrow) and vascular sheathing
(open arrow).
Erythematous, keratotic plaques of the palms.
was no uveitis. A fungating lesion was present on
the left buccal mucosa. There were bilateral, ery-
thematous, keratotic plaques of the palms and soles
(Fig. 2). Lymphadenopathy was present in the sub-
mandibular, axillary, and epitrochlear regions. The
remainder of the general and neurologic examina-
tions was unremarkable. A gynecologic evaluation
was remarkable for a greenish vaginal discharge
which was positive for Trichomonas sp. by wet-
mount examination.
An analysis ofcerebrospinal fluid (CSF) obtained
by lumbar puncture revealed slightly turbid fluid
with aWBC count of 9,640/t,1 (15% polymorphonu-
clear neutrophil leukocytes, 84% small mononu-
clear cells, and 1% large mononuclear cells). The
glucose was low at 30 mg/dl, and the total protein
was elevated at 156 mg/dl. The CSF VDRL was
reactive at a dilution of 1:16. CSF cultures for bacte-
ria, fungi, mycobacteria, and viral organisms were
negative. Computed tomography of the head was
normal. CBC, blood urea nitrogen, and creatinine
were normal. Biopsies of the left palm and left buc-
cal mucosa showed lichenoid psoriasiform derma-
titis consistent with secondary syphilis. EIA and
Western blot for HIV were positive. The CD4 count
was 363/11. A serum pregnancy test was negative.
A diagnosis of neurosyphilis was made, and the
patient was treated with 2 million units (mlU) of
intravenous (IV) penicillin G q 4 h for 10 days. After
9 days of therapy, a repeat CSF analysis showed
a marked decline in WBCs (190/pl, 100% small
mononuclear cells) and total protein (78 mg/dl).
The glucose remained low at 38 mg/dl. The VDRL
was essentially unchanged at 1:8. Six weeks after
she had completed therapy, the CSF WBC count
was 39/Ixl (100% small mononuclear cells), with a
total protein of 49 mg/dl and a normal glucose of
46 mg/dl. The CSF VDRL had declined to 1:2.
The serum VDRL was 1:128. Trimethoprim/sulfa-
methoxazole was begun for prophylaxis of Pneumo-
cystis carinii pneumonia at the time of discharge.
While the patient was on zidovudine, 500 mg/day,
her CD4 count rose to 520/1. Her rash and oral
lesions resolved. Her vision was unimproved and
her ophthalmological examination was unchanged,
which was interpreted as irreversible damage to the
retina, not ongoing infection. Therefore, additional
anti-infective therapy was not administered.
DISCUSSION
This case of neurosyphilis in an HIV-seropositive
woman underscores important trends in the chang-
ing epidemiology of sexually transmitted diseases,
serves as an example of the aggressive nature of
syphilis in HIV-infected individuals, and highlights
important questions in the treatment of syphilis
when there is concomitant HIV infection.
The incidence of syphilis rose sharply in the
mid-1980s, reversing a decline which had begun in
the 1940s. In women, the incidence of syphilis has
abated considerably since then, but has remained
significantly above the nadir achieved in the late
1970s and the 1980s. The incidence of HIV infec-
tion among women has risen steadily in recent
years. In 1994, 18% of all acquired immunodefi-
ciency syndrome (AIDS) cases occurred in females
>12 years of age, nearly 3-fold greater than the
proportion reported for 1985. AIDS is now the
fourth leading cause of death among women aged
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25-44 years in the United States. Two-thirds of
the women with AIDS report having had sex with
at-risk partners, and over one-quarter have histories
of injecting-drug use. The proportion of heterosex-
ually acquired cases of AIDS has tripled from 2%
in 1981 to 7% in 1993. Thus, the epidemiologic
trends of HIV infection in the United States are
shifting dramatically. Although AIDS was once con-
sidered to be an illness afflicting almost exclusively
young homosexual men, a substantial proportion of
its victims are now women infected through hetero-
sexual intercourse or injecting-drug use.
Given the increasing prevalence of both of these
infections, one might expect that the rate ofcoinfec-
tion is also rising. Indeed, the presence of syphilis
is considered a risk factor for HIV infection. Precise
data on the number of men and women who are
coinfected with syphilis and HIV are not available,
but several reports clearly indicate that coinfection
is becoming more prevalent,
s-8
It has also become apparent that the pathobiol-
ogy of syphilis in HIV-infected patients differs from
that in immunocompetent patients in several ways.
Neurosyphilis appears to occur both more fre-
quently and with a shorter latency in HIV-infected
individuals. In untreated immunocompetent indi-
viduals, the progression to neurosyphilis occurs
from 5 to 30 years after infection with syphilis. In
one series of HIV-infected patients, however, more
rapid progression was suggested both by the rela-
tively young age (mean 37 years) of the patients
and by its rapid onset. In this series, 2 patients
developed neurosyphilis within 6 months of receiv-
ing the standard treatment for latent syphilis. Simi-
larly, in a series of patients from Atlanta, the median
interval between the last dose of penicillin and the
diagnosis of neurosyphilis was 8 months. This rapid
progression occurs even among HIV-infected pa-
tients who possess relatively good immune function
by current standards. In most patients with HIV
infection, opportunistic infections, such as pneumo-
nia caused by Pneumocystis carinii, generally do not
occur before the CD4 count drops to <200/l,1. The
patients in the Atlanta series had a median CD4
count of 344/11 (similar to that of our patient), and
7/11 patients had CD4 counts >200/Ixl (range 23-
972/i,1).
In AIDS patients, early neurosyphilis affects me-
sodermal structures such as the meninges and blood
vessels and may cause asymptomatic illness, menin-
gitis, cranial-nerve abnormalities (most commonly
the second and eighth nerves6), and stroke. Oph-
thalmologic disease, as described in our patient, is
common, manifested as uveitis, retinitis, or ret-
robulbar neuritis.6-’1 Ocular symptoms include
blurred vision and blindness. These characteristics
stand in contrast to those of late neurosyphilis as
described in the preantibiotic era. In these cases,
the direct involvement of neurons leads to the clas-
sic manifestations of tabes dorsalis, general paresis,
and dementia,
The traditional classification of syphilis distin-
guishes the secondary stage of illness, most com-
monly presenting as a rash, from the tertiary phase
(neurosyphilis and cardiovascular and gummatous
syphilis), in which rash is uncommon. This classifi-
cation may not apply in the presence of HIV infec-
tion. As in our case, 4/11 patients from the Atlanta
series had dermatologic manifestations of secondary
syphilis at the time they were diagnosed with neuro-
syphilis. Their lesions were typically papulosqua-
mous or maculopapular rashes involving the palms
or soles. Patchy alopecia was also seen. Thus, in
HIV-infected patients, lesions of secondary syphilis
may be a sign of much more extensive and seri-
ous disease.
A common theme in the literature of syphilis and
HIV infection is the progression to neurosyphilis
despite appropriate treatment at the time of the
original diagnosis of syphilis.7’8’ The reason for the
ineffectiveness of treatment is not clear, but likely
results from the inability of the HIV-infected host
to eradicate the infecting organisms. Obviously,
the previously recommended regimen of benza-
thine penicillin G [a single intramuscular (IM) dose
of 2.4 mlU] for the treatment of secondary syphilis
in HIV-infected patients does not reliably eradicate
treponemes from the CSF,
11 probably because peni-
cillin does not reach detectable concentrations in
the CSF when administered in this form. In the
Atlanta series, in contrast, after the patients’ treat-
ment with high-dose penicillin G (3-4 mlU IV q 4
h for 10 days), treponemes were no longer detect-
able in the 3 patients who had positive pretreatment
CSF. Despite high-dose IV penicillin, patient in
this series developed a stroke secondary to menin-
govascular syphilis within 2 months of completing
the therapy. Thus, even the most intense of pre-
viously recommended regimens does not ensure
that the disease progression will be interrupted.
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In the absense of large clinical trials, there is
considerable uncertainty about what the proper
evaluation and treatment for patients with syphilis
and HIV infection should be. Certainly, the pres-
ence of one infection should always prompt testing
for the other. For early (primary or secondary) syphi-
lis with coexisting HIV infection, some experts rec-
ommend empiric therapy of either 3 doses of ben-
zathine penicillin, 2.4 mlU IM given at weekly
intervals, or 10 daily doses of 1.2 mlU of procaine
penicillin, The current guidelines from the Centers
for Disease Control and Prevention (CDC) con-
tinue to recommend dose of 2.4 mlU of benza-
thine penicillin for either condition, lz For latent
syphilis, the CDC recommends 3 doses of benza-
thine penicillin. We prefer the more aggressive ap-
proach to therapy.
Experts differ on the need for a CSF examination
in a patient with HIV infection and early syphilis.
Some recommend empiric treatment and others
recommend routine analysis of the CSF. 1 However,
there is uniform agreement that a patient with latent
syphilis or any evidence of neurologic abnormality
should have an examination of the CSF. Patients
in any stage of syphilis require extremely close fol-
low-up to be certain that the serumVDRL declines
appropriately. For a patient with documented neu-
rosyphilis, repeat CSF examinations are required.
Interestingly, the initial CSF WBC count in our
patient was considerably higher than that reported
in the Atlanta series (9,640/p1 vs. a mean of 38/11
with a range of 4-210/11). With such a high CSF
WBC count, a turbid sample would be expected.
It was described as only "slightly turbid," raising
the strong possibility that the initial CSF WBC
was incorrect.
In conclusion, our case exemplifies the rising
incidence of syphilis and HIV infection among
women, the aggressive nature of syphilis in HIV-
infected patients, and the difficulty in treating pa-
tients with these 2 infections. Syphilologists agree
that such a patient should be followed closely after
treatment to be certain that the serum VDRL de-
clines appropriately and that, at the very least, a
strong index of suspicion should be maintained for
neurosyphilis, even after the patient has been
treated. The precise treatment for a patient with
early syphilis and the need for an examination of
the CSF remain areas for investigation.
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